Skip to main content

Advertisement

SpringerLink
Log in

Model-Based Evaluation of Diabetic Foot Prevention Strategies in Austria

  • Published:
Health Care Management Science Aims and scope Submit manuscript

Abstract

Diabetes mellitus affects approximately 171 million individuals worldwide. The costs of the adult form of diabetic mellitus account for up to 6% of total health care expenditures in industrialized countries. About 25% of these diabetics develop disabling and most painful foot complications accounting for about 17% of the direct lifetime costs. Diabetic foot prevention programs have been recently introduced in some Austrian federal states to meet the diabetic health targets of the Austrian Health Plan and the St. Vincent Declaration. We developed a new age-group specific Markov model combined with a Monte Carlo simulation model to help policymakers analyze the cost-effectiveness of such programs compared to the status quo in terms of incremental costs per quality-adjusted life years gained (QALY). The Markov model revealed that diabetic foot prevention programs were cost saving when targeted at patients at high risk and mainly cost-effective when targeted at patients with mild symptoms. The Monte Carlo simulation showed that only large scope prevention programs would fulfill the specified reductions in the number of diabetic foot complications as defined in the Austrian Health Plan and the St. Vincent Declaration. Our results clearly indicate the enormous impact of diabetic foot prevention programs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A. Amos, D. McCarty, and P. Zimmet, The rising global burden of diabetes and its complications: Estimates and projections to year 2010, Diabetic Medicine 14 (1997) S1–S85.

    Article  Google Scholar 

  2. J. Apelqvist, G. Ragnarson-Tennvall, J. Larsson, et al., Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting, Foot Ankle International 16(7) (1995) 388–394.

    ISI  Google Scholar 

  3. J. Apelqvist, G. Ragnarson-Tennvall, U. Persson, et al., Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation, Journal of Internal Medicine 235(5) (1994) 463–471.

    Article  ISI  Google Scholar 

  4. D.G. Armstrong and L.A. Lavery, Diabetic foot ulcers: Prevention, diagnosis and classification, American Family Physician 57(6) (1998) 1325–1332.

    ISI  Google Scholar 

  5. A. Bagust, P. Hopkinson, W. Maier, and C. Currie, An economic model of the long-term helath care burden of type II diabetes, Diabetologia 44 (2001) 2140–2155.

    Article  ISI  Google Scholar 

  6. M. Berger, Diabetes Mellitus (Urban und Schwarzenberg, Munich, 1995).

    Google Scholar 

  7. B.O. Boehm, K.-D. Palitzsch, C. Rosak, et al., Klinische Diabetologie (Springer Verlag, Berlin, 2001).

    Google Scholar 

  8. A.J. Boulton, Lowering the risk of neuropathy, foot ulcers and amputations, Diabetic Medicine 15 (1998) S57–S59.

    ISI  Google Scholar 

  9. S.C. Brailsford, R. Davies, C. Canning, and P.J. Roderick, Evaluating screening policies for the early detection of retinopathy in patients with non-insulin dependent diabetes, Health Care Management Science 1(2) (1998) 115–124.

    Article  Google Scholar 

  10. M. Brandle, H. Zhou, B. Smith, et al., The direct medical costs of type 2 diabetes, Diabetes Care 26(8) (2003) 2300–2304.

    ISI  Google Scholar 

  11. G. Bronneberg and I. Rottenhofer, Schulungsmodelle fuer Typ-II-Diabetes (Oesterreichisches Bundesinstitut für Gesundheitswesen, Vienna, 1999).

  12. A. Brugger, Betreuungskonzepte für Patienten mit Typ-2-Diabetes in Oesterreich, Diabetes Forum (1) (2002) 40ff.

  13. J. Caro, A. Ward, and J. O'Brien, Lifetime costs of complications resulting from type 2 diabetes in the U.S., Diabetes Care 25(3) (2002) 476–481.

    ISI  Google Scholar 

  14. T. Chen, M. Yen, and T. Tung, A computer simulation model for cost-effectiveness analysis of mass screening fot type 2 diabetes mellitus, Diabetes Research and Clinical Practice 54 (2001) S37–S42.

    ISI  Google Scholar 

  15. D. Cheta, Preventing Diabetes: Theory, Practice and New Approaches (John Wiley & Sons Ltd., Chichester, 1999).

    Google Scholar 

  16. R.C. Eastman, J.C. Javitt, W.H. Herman, et al., Model of complications of NIDDM. I. Model construction and assumptions, Diabetes Care 20(5) (1997) 725–734.

    ISI  Google Scholar 

  17. M.H. Eckman, S. Greenfield, W.C. Mackey, et al., Foot infections in diabetic patients: Decision and cost-effectiveness analyses, Journal of the American Medical Association 273(9) (1995) 712–720.

    Article  Google Scholar 

  18. J.M. Ekoé, R. Williams, and P. Zimmet, Introduction, in: The Epidemiology of Diabetes Mellitus—An International Perspective, eds. J.M. Ekoé, P. Zimmet and R. Williams (John Wiley & Sons Ltd., Chichester, 2001).

    Google Scholar 

  19. J.M. Ekoé and P. Zimmet, The clinical syndrome and the biochemical definition, in: The Epidemiology of Diabetes Mellitus — An International Perspective, eds. J.M. Ekoé, P. Zimmet, and R. Williams (John Wiley & Sons Ltd., Chichester, 2001).

    Google Scholar 

  20. R. Furlan, E. Butti, S. Pluchino, and G. Martino, Gene therapy for autoimmune diseases, Current Opinion in Molecular Therapeutics 6(5) (2004) 525–536.

    ISI  Google Scholar 

  21. M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein, Cost-Effectiveness in Health and Medicine (Oxford University Press, N.Y., 1996).

    Google Scholar 

  22. J.D. Graham, P.S. Corso, J.M. Morris, et al., Evaluating the cost-effectiveness of clinical and public health measures, Annual Review of Public Health 19(1998) 125–152.

    Article  ISI  Google Scholar 

  23. A. Green, E. Gale, and C. Patterson, Incidence of childhood-onset insulin-dependent diabetes mellitus: The EURODIAB ACE study, Lancet 339 (1992) 905–909.

    ISI  Google Scholar 

  24. M. Harris, W. Hadden, W. Knowler, and P. Bennett, Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20–74 years, Diabetes 36(1987) 523–534.

    ISI  Google Scholar 

  25. W.M. Hart, C. Espinosa, and J. Rovira, A simulation model of the cost of the incidence of IDDM in Spain, Diabetologia 40(3) (1997) 311–318.

    Article  ISI  Google Scholar 

  26. P. Hogan, T. Dall, and P. Nikolov, Economic costs of diabetes in the US in 2002, Diabetes Care 26(3) (2003) 917–932.

    Google Scholar 

  27. International Working Group on the Diabetic Foot and http://www.diabetic-foot-consensus.com, International consensus on the diabetic foot, (access 27–05–2003).

  28. International Diabetes Foundation and http://www.idf.org/e-atlas, E-Atlas, (access 22-07-2003).

  29. W. Jeffcoate and R. Macfarlane, The Diabetic Foot: An Illustrated Guide to Management (Chapman & Hall Medical, London, 1995).

    Google Scholar 

  30. W.J. Jeffcoate and K.G. Harding, Diabetic foot ulcers, Lancet 361(9368) (2003) 1545–1551.

    Article  ISI  Google Scholar 

  31. D. Klonoff and D. Schwartz, An economic analysis of interventions for diabetes, Diabetes Care 23(3) (2000) 390–404.

    ISI  Google Scholar 

  32. K.M. Kuntz and M.C. Weinstein, Modelling in economic evaluation, in: Economic Evaluation in Health Care: Merging Theory With Practice, eds. M. Drummond and A. McGuire (Oxford University Press, Oxford, 2001).

    Google Scholar 

  33. L.A. Lavery, D.G. Armstrong, and L.B. Harkless, Classification of diabetic foot wounds, Ostomy Wound Management 43(2) (1997) 44–48.

    Google Scholar 

  34. C. Leventan, Diabetes prevention: How about now? Clinical Diabetes 19(1) (2001) 34.

    Google Scholar 

  35. A. Liebl, A. Spannheimer, U. Reitberger, et al., Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study, Medizinische Klinink 97(12) (2002) 713–719.

    Google Scholar 

  36. J.M. Malone, M. Snyder, G. Anderson, et al., Prevention of amputation by diabetic education, American Journal of Surgery 158(6) (1989) 520–523.

    Article  ISI  Google Scholar 

  37. H. Mehnert, Typ-2-Diabetes: Pathogenese, Diagnostik, Therapie, Folgeschaeden (Medikon Verlag, Munich, 2000).

    Google Scholar 

  38. A. Mokdad, E. Ford, B. Bowman, et al., Diabetes trends in the US: 1990-1998, Diabetes Care 23 (2000) 1278–1283.

    ISI  Google Scholar 

  39. A. Mokdad, E. Ford, B. Bowman, et al., The continuing increase in diabetes in the US, Diabetes Care 24 (2001) 412.

    Google Scholar 

  40. A.H. Mokdad, M.K. Serdula, W.H. Dietz, et al., The spread of the obesity epidemic in the United States—1991–1998, Journal of the American Medical Association 282(1999) 1519–1522.

    Article  Google Scholar 

  41. S. Moss, R. Klein, and B. Klein, Long-term incidence of lower-extremity amputations in a diabetic population, Archives of Family Medicine 5(7) (1996) 391–398.

    Article  ISI  Google Scholar 

  42. I. Muhlhauser, M. Sulzer, and M. Berger, Quality assessment of diabetes care according to the recommendations of the St. Vincent Declaration: A population-based study in a rural area of Austria, Diabetologia 35(5) (1992) 429–435.

    ISI  Google Scholar 

  43. K. Narayan, J. Boyle, T. Thompson, et al., Lifetime risk for diabetes mellitus in the United States, Journal of the American Medical Association 290(14) (2003) 1884–1890.

    Article  Google Scholar 

  44. K. Narayan, E. Gregg, A. Fagot-Campagna, M. Engelgau, et al., Diabetes: A common, growing, serious, costly, and potentially preventable public health problem, Diabetes Research and Clinical Practice 50 (2000) S77–S84.

    Article  ISI  Google Scholar 

  45. J.A. O'Brien, A.R. Patrick, and J. Caro, Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000, Clinical Therapy 25(3) (2003) 1017–1038.

    Article  Google Scholar 

  46. Oesterreichische Akademie der Wissenschaften, Diabetisches Fuß-Syndrom, Health Technology Assessment Newsletter: Evaluation medizinischer Interventionen (5) (2002) 3.

  47. D.A. Ollendorf, J.G. Kotsanos, W.J. Wishner, et al., Potential economic benefits of lower-extremity amputation prevention strategies in diabetes, Diabetes Care 21(8) (1998) 1240–1245.

    ISI  Google Scholar 

  48. M.M. Ortegon, W.K. Redekop, and L.W. Niessen, Cost-effectiveness of prevention and treatment of the diabetic foot, Diabetes Care 27(4) (2004) 901–907.

    ISI  Google Scholar 

  49. D.K. Owens, Interpretation of cost-effectiveness analyses, Journal of General Internal Medicine 13(10) (1998) 716–717.

    ISI  Google Scholar 

  50. E.-M. Pesendorfer, Oekonomische Evaluation von Praeventionsmaßnahmen zur Verminderung von Spaetkomplikationen des Diabetes Mellitus, Master's thesis, University of Vienna, Vienna (2003).

  51. T.R. Pieber, A. Holler, and G.A. Brunner, et al., Diabetesbetreuung in Oesterreich 5 Jahre nach der St. Vincent-Erklaerung, Wiener Klinische Wochenschrift 107(15) (1995) 451–456.

    ISI  Google Scholar 

  52. G. Ragnarson-Tennvall and J. Apelqvist, Prevention of diabetes-related foot ulcers and amputations: A cost-utility analysis based on Markov model simulations, Diabetologia 44(11) (2001) 2077–2087.

    Google Scholar 

  53. M.S. Rauner, K. Heidenberger, and E.-M. Pesendorfer, Using a Markov model to evaluate the cost-effectiveness of diabetic foot prevention strategies in Austria, in: Western Multiconference, Proceedings of the International Conference on Health Sciences Simulation, January 18-22, 2004, San Diego, CA, eds. J. Anderson and M. Katzper (The Society of Simulation International, San Diego, CA, 2004), 63–68.

  54. G.E. Reiber, Diabetic foot care, Diabetes Care 15(1992) S29–S31.

    Google Scholar 

  55. G.E. Reiber, R.E. Pecoraro, and T.D. Koepsell, Risk factors for amputation in patients with diabetes mellitus. A case-control study, Annals of Internal Medicine 117(2) (1992) 97–105.

    ISI  Google Scholar 

  56. F.A. Sonnenberg and J.R. Beck, Markov models in medical decision making: A practical guide, Medical Decision Making 13(4) (1993) 322–338.

    ISI  Google Scholar 

  57. M. Spraul, Praevention des diabetischen Fußsyndroms, Der Internist 40 (1999) 1056–1066.

    Article  Google Scholar 

  58. E. Standl, Zur Epidemiologie des diabetischen Fußsyndroms, Diabetes und Stoffwechsel 9 (2000) 339–342.

    Google Scholar 

  59. Statistik Austria, Gesundheitszustand und Konsum Medizinischer Leistungen (Verlag Oesterreich GmbH, Vienna, 2002).

    Google Scholar 

  60. T.O. Tengs, M.E. Adams, J.S. Pliskin, et al., Five-hundred life-saving interventions and their cost-effectiveness, Risk Analysis 15(3) (1995) 369–390.

    ISI  Google Scholar 

  61. TreeAge Software Inc., Healthcare User's Manual Data 4.0 (TreeAge Software Inc, Williamstown, MA, 2001).

    Google Scholar 

  62. J. Tuomilehto, J. Lindstrom, and J. Eriksson, et al., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, New England Journal of Medicine 344(18) (2001) 1343–1350.

    Article  ISI  Google Scholar 

  63. W.H. van Houtum, L.A. Lavery, and L.B. Harkless, The costs of diabetes-related lower extremity amputations in the Netherlands, Diabetic Medicine 12(9) (1995) 777–781.

    Google Scholar 

  64. R. Waneck, Nationaler Oesterreichischer Gesundheitsplan (Federal Ministry of Health and Women, Vienna, 2002).

    Google Scholar 

  65. R. Williams, Ascertainment, prevalance, incidence and temporal trends, in: The Epidemiology of Diabetes Mellitus, eds. J.M. Ekoé, P. Zimmet, and R. Williams (John Wiley & Sons Ltd., Chichester, 2001).

    Google Scholar 

  66. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, (WHO, Geneva, 1999).

  67. World Health Organization and http://www.who.int, Diabetes Mellitus, (access 29–04-2005).

  68. World Health Organization International Diabetes Federation, Diabetes Care and Research in Europe: The St. Vincent Declaration Action Programme, (WHO, Geneva, 1992).

  69. M.J. Young and A.J.M. Boulton, The diabetic foot, in: Diabetes in Old Age, eds. A.J. Sinclair and P. Finucane (John Wiley & Sons, Ltd., Chichester, 2001).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Innovation and Technology Management, University of Vienna, Faculty of Business, Economics and Statistics, Bruenner Str. 72, A-1210, Vienna, Austria

    Marion S. Rauner & Kurt Heidenberger

  2. Department of Organisation and Planning, University of Vienna, Faculty of Business, Economics and Statistics, Bruenner Str. 72, A-1210, Vienna, Austria

    Eva-Maria Pesendorfer

Authors
  1. Marion S. Rauner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurt Heidenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eva-Maria Pesendorfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marion S. Rauner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rauner, M.S., Heidenberger, K. & Pesendorfer, EM. Model-Based Evaluation of Diabetic Foot Prevention Strategies in Austria. Health Care Manage Sci 8, 253–265 (2005). https://doi.org/10.1007/s10729-005-4136-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10729-005-4136-6

Keywords

Search

Navigation